MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,784
Beneficiaries
—
Total drug cost
$347K
Distinct drugs
93
Brand share
17.8%
Top prescribed drugs
Losartan Potassium299 claims
Atorvastatin Calcium267 claims
Levothyroxine Sodium259 claims
Rosuvastatin Calcium236 claims
Amlodipine Besylate226 claims
QUALITY · MIPS · 2024
Final MIPS score
93.8
Quality
80.4
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.79%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
REFERRAL NETWORK
Where Gregory Burfeind's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| IHC HEALTH SERVICES INC | 15 | 44 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE